“…Diagnostically difficult cases were reviewed by an Italian team guided by Dr. Anna Maria Testi (Department of Cellular Biotechnologies and Hematology, University “La Sapienza”, Rome, Italy) via telemedicine sessions . The diagnosis of ALL and AML was confirmed on initial unstained bone marrow (BM) aspiration smears that were transferred from Iraq and stained with May‐Grünwald‐Giemsa and myeloperoxidase at the Department of Pediatrics, Shinshu University School of Medicine . In Jordan, the diagnosis of ALL and AML was confirmed by flow cytometric analysis: CD10, CD19, CD20, CD22, and cytoplasmic CD79a were used for B‐precursor ALL; CD1a, CD2, CD3, CD4, CD5, CD7, CD8, cytoplasmic CD3, and TdT were used for T‐lineage ALL.…”